DNA-cleaving enzymes trigger a repair process that can now be harnessed to correct mutations in the human genome in vitro. This represents another step towards gene-correction strategies for treating human disease.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.

References
Urnov, F. D. et al. Nature 435, 646–651 (2005).
Porteus, M. H. & Baltimore, D. Science 300, 763 (2003).
Bibikova, M. et al. Science 300, 764 (2003).
Kim, Y. G., Cha, J. & Chandrasegaran, S. Proc. Natl Acad. Sci. USA 93, 1156–1160 (1996).
Tupler, R. et al. Nature 409, 832–833 (2001).
Klug, A. FEBS Lett. 579, 892–894 (2005).
Cavazzana-Calvo, M. et al. Science 288, 669–672 (2000).
Hacein-Bey-Abina, S. et al. N. Engl. J. Med. 348, 255–256 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
High, K. The moving finger. Nature 435, 577–579 (2005). https://doi.org/10.1038/435577a
Published:
Issue Date:
DOI: https://doi.org/10.1038/435577a
Further reading
-
Transmembrane routes of cationic liposome-mediated gene delivery using human throat epidermis cancer cells
Biotechnology Letters (2014)
-
Challenges with advanced therapy medicinal products and how to meet them
Nature Reviews Drug Discovery (2010)
-
Genetic medicines: treatment strategies for hereditary disorders
Nature Reviews Genetics (2006)